Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Axitinib + Fecal Microbiota Transplantation (FMT) + Pembrolizumab & Renal Cell Carcinoma (RCC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

The randomized, placebo-controlled, double-blind treatment trial NCT04758507 - TACITO - 1L - Axitinib + Fecal Microbiota Transplantation (FMT) + Pembrolizumab vs Axitinib + Pembrolizumab & Renal Cell Carcinoma (RCC) revealed that the preliminary results demonstrate, for the first time, the role of FMT in enhancing the effectiveness of ICIs-based therapies in patients with mRCC (1)

(1) Ciccarese et al. 2024 Annals of Oncology 35(Suppl_2): S1264-S1264

7/1/2026